Rochwerg, Bram;
Agarwal, Arnav;
Zeng, Linan;
Leo, Yee-Sin;
Appiah, John Adabie;
Agoritsas, Thomas;
Bartoszko, Jessica;
Brignardello-Petersen, Romina;
Ergan, Begum;
Ge, Long;
Geduld, Heike;
Gershengorn, Hayley B;
Manai, Hela;
Huang, Minhua;
Lamontagne, François;
Kanda, Seema;
Kawano-Dourado, Leticia;
Kurian, Linda;
Kwizera, Arthur;
Murthy, Srinivas;
Qadir, Nida;
Siemieniuk, Reed;
Silvestre, Maria Asuncion;
Vandvik, Per Olav;
Ye, Zhikang;
Zeraatkar, Dena;
Guyatt, Gordon.
Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/patogenicidad,
Infecciones por Coronavirus/diagnóstico por imagen,
Infecciones por Coronavirus/complicaciones,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/diagnóstico por imagen,
Neumonía Viral/tratamiento farmacológico,
Neumonía Viral/complicaciones,
Pandemias/estadística & datos numéricos,
Brote de los Síntomas,
Grupos de Riesgo,
China/epidemiología,
Neumonía Asociada a la Atención Médica/diagnóstico,
Personal de Salud/organización & administración,
Portador Sano/transmisión,
Transmisión Vertical de Enfermedad Infecciosa/prevención & control
Moores, Lisa K;
Tritschler, Tobias;
Brosnahan, Shari;
Carrier, Marc;
Collen, Jacob F;
Doerschug, Kevin;
Holley, Aaron B;
Jimenez, David;
Gal, Gregoire Le;
Rali, Parth;
Wells, Philip.
Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...
China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries
...
Betacoronavirus/efectos de los fármacos,
Neumonía Viral/epidemiología,
Infecciones por Coronavirus/epidemiología,
China/epidemiología,
Pandemias/prevención & control,
Pandemias/estadística & datos numéricos,
Monitoreo Epidemiológico,
Gestión de la Información en Salud/métodos,
Interferones/uso terapéutico,
Lopinavir/uso terapéutico,
Ritonavir/uso terapéutico,
Ribavirina/uso terapéutico,
Cloroquina/uso terapéutico,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico
Bhimraj, Adarsh;
Morgan, Rebecca L;
Shumaker, Amy Hirsch;
Lavergne, Valery;
Baden, Lindsey;
Cheng, Vincent Chi-Chung;
Edwards, Kathryn M;
Gandhi, Rajesh;
Muller, William J;
O’Horo, John C;
Shoham, Shmuel;
Murad, M. Hassan;
Mustafa, Reem A;
Sultan, Shahnaz;
Falck-Ytter, Yngve.
Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19....
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection....
The purpose of this guideline is to maximise the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources....
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnóstico Clínico/diagnóstico,
Betacoronavirus/efectos de los fármacos,
Infecciones por Coronavirus/diagnóstico,
Neumonía Viral/diagnóstico,
Hipoxia/diagnóstico,
Gravedad del Paciente,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico,
Dexametasona/uso terapéutico,
Lactancia Materna,
Antivirales/uso terapéutico,
Hidroxicloroquina/uso terapéutico,
Colchicina/uso terapéutico,
Plasma/inmunología,
Darunavir/uso terapéutico,
Interferones/uso terapéutico,
Práctica Clínica Basada en la Evidencia/métodos
Multiple questions have been raised regarding the gastrointestinal and liver manifestations of COVID-19 infection, and implications of SARS-CoV-2 infection on gastrointestinal endoscopy. A joint society statement of the American Gastroenterological Association (AGA), the American Association for the Stud...
